Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Madison Square Garden
MSGE
$2.1B
| $2.97M | ﹤0.01% |
74,359
-2,600
| -3% | -$104K |
|
1577
Century Communities
CCS
$2B
| $2.97M | ﹤0.01% |
52,666
-2,000
| -4% | -$113K |
|
1578
Seadrill
SDRL
$2.04B
| $2.96M | ﹤0.01% |
+112,800
| New | +$2.96M |
|
1579
NCR Voyix
VYX
$1.77B
| $2.96M | ﹤0.01% |
252,059
-16,600
| -6% | -$195K |
|
1580
Knowles
KN
$1.9B
| $2.95M | ﹤0.01% |
167,500
-3,100
| -2% | -$54.6K |
|
1581
Hafnia
HAFN
$3.02B
| $2.95M | ﹤0.01% |
589,048
-7,340
| -1% | -$36.7K |
|
1582
TMC The Metals Company
TMC
$2.24B
| $2.94M | ﹤0.01% |
+445,500
| New | +$2.94M |
|
1583
Beam Therapeutics
BEAM
$2.08B
| $2.94M | ﹤0.01% |
172,600
| – | – |
|
1584
La-Z-Boy
LZB
$1.39B
| $2.93M | ﹤0.01% |
78,900
-1,500
| -2% | -$55.8K |
|
1585
Adeia
ADEA
$1.71B
| $2.93M | ﹤0.01% |
207,146
-4,500
| -2% | -$63.6K |
|
1586
International Seaways
INSW
$2.33B
| $2.91M | ﹤0.01% |
79,900
-1,100
| -1% | -$40.1K |
|
1587
Liberty Live Group Series A
LLYVA
$8.95B
| $2.91M | ﹤0.01% |
36,576
-3,100
| -8% | -$246K |
|
1588
Teladoc Health
TDOC
$1.36B
| $2.91M | ﹤0.01% |
333,602
| – | – |
|
|
SII
1589
Sprott
SII
$1.8B
| $2.9M | ﹤0.01% |
42,175
| – | – |
|
1590
Alaska Air
ALK
$7.31B
| $2.9M | ﹤0.01% |
58,600
-2,900
| -5% | -$143K |
|
|
CGAU
1591
Centerra Gold
CGAU
$1.88B
| $2.89M | ﹤0.01% |
403,400
-8,700
| -2% | -$62.4K |
|
1592
Certara
CERT
$1.81B
| $2.89M | ﹤0.01% |
246,800
-2,700
| -1% | -$31.6K |
|
1593
Viasat
VSAT
$4.1B
| $2.88M | ﹤0.01% |
197,224
+21,300
| +12% | +$311K |
|
1594
Helmerich & Payne
HP
$2.1B
| $2.88M | ﹤0.01% |
189,800
-1,500
| -0.8% | -$22.7K |
|
1595
Recursion Pharmaceuticals
RXRX
$2.11B
| $2.86M | ﹤0.01% |
566,200
+82,900
| +17% | +$419K |
|
1596
TripAdvisor
TRIP
$2.06B
| $2.86M | ﹤0.01% |
219,300
-1,300
| -0.6% | -$17K |
|
1597
Arcutis Biotherapeutics
ARQT
$2.07B
| $2.86M | ﹤0.01% |
204,000
| – | – |
|
1598
Sarepta Therapeutics
SRPT
$1.82B
| $2.85M | ﹤0.01% |
166,483
| – | – |
|
1599
Liberty Global Class C
LBTYK
$4.07B
| $2.85M | ﹤0.01% |
275,970
-23,400
| -8% | -$241K |
|
1600
Xometry
XMTR
$2.59B
| $2.83M | ﹤0.01% |
83,900
| – | – |
|